SLNOEUR
SOLENO THERAPEUTICS INC
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 4 parsed filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Apr 30, 2026 observed May 7, 2026 filed · 7d Schedule 13G amendment | Reported reduction | 193 -5.6K | 12.00% 0.00 pts | |||
| T. Rowe Price Associates CIK0000080255 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Earliest Schedule 13G amendment found | 1.0M | 12.00% | |||
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 2.7M | 12.00% |